Analysis and Verification of Glycosylation Characteristics of Septic Acute Kidney Injury
Si Chen,Hua Gan
DOI: https://doi.org/10.2147/jir.s437266
IF: 4.5
2023-12-05
Journal of Inflammation Research
Abstract:Si Chen, Hua Gan Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China Correspondence: Hua Gan, Email Background: Septic acute kidney injury (S-AKI) results from an imbalance in the regulation of systemic inflammatory responses. Glycosylation plays an important role in inflammatory responses. However, the relationship between S-AKI and glycosylation is unclear. Methods: The datasets of the public platform were analyzed using R language to obtain glycosylation-related differentially expressed genes (GRDEGs) in S-AKI. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analyses were performed for GRDEGs. Hub genes were obtained using three machine learning algorithms and their diagnostic values were evaluated using receiver operating characteristic (ROC) curves. The relationships between the hub genes, immune cells, and signaling pathways were analyzed, and the upstream miRNAs, transcription factors, and compounds of the hub genes were predicted. Mouse models of AKI with sepsis were constructed and the expression of the hub genes was verified. Results: We obtained 45 GRDEGs that were mainly enriched in glycoprotein metabolism and immune inflammatory response, such as "O-glycan biosynthesis", "phagosome", "pathogenic Escherichia coli infection", "glycosyltransferase activity", etc. Seven hub genes that have potential diagnostic value were identified and were associated with the regulation of immune cells. Through gene set enrichment analysis (GSEA) of hub genes, it was found that these genes may be involved in metabolism, signaling transduction, and inflammation-related signaling pathways, such as "metabolism of amino and derivatives", "RHO GTPase cycle", "transport of small molecules", "neutrophil degranulation", "immune system", etc. We then predicted 100 miRNAs, 60 TFs, and 23 compounds of the hub genes using forecasting tools. Finally, animal experiments confirmed the differential expression of ASGR1, UMOD, SPTBN1, and ADAMTS17. Conclusion: This study identified and validated four biomarkers associated with abnormal glycosylation that could be potential targets for AKI in sepsis. Keywords: acute kidney injury, sepsis, glycosylation, hub genes, bioinformatics Severe sepsis frequently presents with multiorgan dysfunction, with the kidneys being particularly susceptible. The mortality rate of sepsis accompanied by acute kidney injury (AKI) is much higher than that without AKI, resulting in a significant societal and medical burden. 1,2 Consequently, the timely diagnosis and treatment of AKI in sepsis are of utmost importance. Several early markers of renal injury, such as NGAL and KIM-1, have improved early detection of AKI. However, additional biomarkers are needed to predict the severity of AKI in sepsis. 3 Moreover, current treatments are mainly symptomatic, including anti-infective measures and fluid replacement, and there is still a lack of targeted therapies. Although the concept of regulating inflammation in sepsis has great theoretical potential, previous attempts at targeted immune regulation of inflammatory mediators have been unsuccessful. 4,5 Consequently, it is necessary to understand the mechanisms of inflammation regulation and propose novel approaches to diagnose and treat AKI in sepsis. The regulation of glycosylation during inflammation has become a hot topic. Several studies have explored the role of glycosylation in acute inflammation. Significant abnormalities in glycosylation have been observed in the pathological process of sepsis, the main features of which are decreased GlcNAc separation and increased core 1/3o-glycans. 6,7 Studies have also described subtypes of glycoproteins, such as alpha-1-antichymotrypsin and IgG. 8–10 In patients with severe coronavirus disease-2019 (COVID-19) infection, high concentrations of afucosylated IgG antibodies amplify proinflammatory cytokine release and acute phase responses; therefore, antibody glycosylation plays a key role in the immune response to enveloped viruses, including in COVID-19. 11 These glycosylation abnormalities have been found to have a significant correlation with the prognosis of the patient. 12,13 Furthermore, the impact of abnormal glycosylation facilitated by glycoproteins on the release of high-mobility proteins and their consequential effects on the inflammatory response have been acknowledged. 14 Proinflammatory cytokines have been shown to modify the synthesis pathways of substrates and the expression of glycosyltransferases necessary for N-glycan biosynthesis. Consequently, these alterations in N-glycosylation can effectively regulate multipl -Abstract Truncated-
immunology